IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Virpax Pharmaceuticals Inc

Q1 2024 vs Q2 2024

Comparing institutional holders between quarters

Quarters

Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile
Parallel Advisors, LLC
UNCHANGED
Shares1 from 1
Change0 (0%)
Value$1 (-$3)
Filed 2024-08-08
Status
Parallel Advisors, LLC
UNCHANGED1100%$4$1-$32024-08-08
Showing 1 of 1 institutions